Compounded Glutathione Injury Lawsuit Lawyers

Victory Medical Center Pharmacy Recalls Compounded Glutathione Distributed in Texas, Florida, and New York After Reports of Serious Adverse Reactions

What Parker Waichman LLP Found

• Three recalled lots have been identified: VMC Compounded Glutathione 200 mg/mL lot numbers 1980571, 1981940, and 1984345, with an August 27, 2026 expiration date.
• Affected products reached multiple states: The recalled glutathione was reportedly distributed to consumers in Texas, Florida, and New York.
• Adverse events have already been reported: Reports include fever, chills, severe headaches, nausea, vomiting, rapid heart rate, blood pressure changes, body aches, and injection-site reactions.
• Endotoxin exposure can become life-threatening: The FDA has previously warned that excessive bacterial endotoxin exposure through injectable glutathione can potentially cause hypotension, shock, and death.
• Injured patients may have potential legal claims: A lawsuit may investigate contamination, compounding practices, testing procedures, warnings, distribution, and when potentially responsible parties knew about the safety problem.

Patients who received compounded injectable glutathione should check their medication immediately following a recallinvolving products that may contain elevated levels of bacterial endotoxins. Victory Medical Center Pharmacy, based in Austin, Texas, voluntarily recalled certain lots of compounded Glutathione 200 mg/mL after quality testing raised concerns about potentially dangerous endotoxin levels. The recalled injectable products were distributed to consumers in Texas, Florida, and New York. Reports associated with the affected products include fever, chills, severe headaches, nausea, vomiting, rapid heart rate, blood pressure changes, body aches, and injection-site reactions.

The contamination concern is particularly serious because the affected product is injected rather than taken orally. Bacterial endotoxins introduced directly into the body can cause an intense inflammatory response. Depending on the exposure and the patient’s condition, reactions can range from fever and chills to dangerously low blood pressure, shock, and potentially death. The FDA has previously investigated excessive bacterial endotoxin contamination involving injectable glutathione and warned that inappropriate endotoxin levels in injected drugs present significant safety concerns.

For patients who became seriously ill after receiving recalled compounded glutathione, the announcement may also raise questions about their legal rights. A pharmaceutical injury claim could require an investigation into how the medication was compounded, what caused the elevated endotoxin levels, whether appropriate quality-control procedures were followed, when the contamination was discovered, and whether patients and healthcare providers received adequate and timely warnings.

Which Compounded Glutathione Products Are Being Recalled?

The recall involves VMC Compounded Glutathione 200 mg/mL supplied in multi-dose vials. According to the recall information reported in connection with the announcement, the affected products include:

• Product: VMC Compounded Glutathione 200 mg/mL
• Dosage form: Multi-dose vial
• Lot number: 1980571
• Lot number: 1981940
• Lot number: 1984345
• Expiration date: August 27, 2026
• Distribution: Texas, Florida, and New York

Patients should not assume their medication is unaffected simply because they have not experienced symptoms. Anyone possessing compounded glutathione associated with these lot numbers should stop using it and follow the pharmacy’s instructions regarding quarantine, retrieval, and proper disposal.

The pharmacy has reportedly been contacting prescribers and patients by telephone and mail and arranging for retrieval of affected products. People who believe they received one of the recalled vials should preserve information identifying the medication, including photographs of the vial, packaging, prescription information, lot number, pharmacy paperwork, receipts, and medical records.

Why Bacterial Endotoxins in Injectable Medications Can Be Dangerous

Bacterial endotoxins are substances associated with certain bacteria. They can remain biologically active even when viable bacteria themselves are no longer present. When excessive endotoxin enters the bloodstream through an injectable medication, the body can mount a powerful inflammatory response.

This makes endotoxin contamination fundamentally different from many ordinary product-quality problems. An injectable medication bypasses many of the body’s normal protective barriers. A contaminated substance can be introduced directly into tissue or circulation, depending upon how it is administered.

The FDA previously investigated adverse reactions involving patients who received intravenous preparations containing compounded L-glutathione. In that investigation, FDA laboratory testing found excessive bacterial endotoxin in tested glutathione powder samples, with some results reaching as high as five times the appropriate limit calculated by the agency based upon the administered dose. The FDA identified possible symptoms of excessive endotoxin exposure including fever, chills, muscle pain, headache, nausea, vomiting, low blood pressure, shock, and death.

That history demonstrates why elevated endotoxin findings involving injectable glutathione warrant immediate attention.

Adverse Reactions Reported in Connection With the Glutathione Recall

Victory Medical Center Pharmacy has reportedly received adverse-event reports involving patients who received the affected compounded glutathione. Reported reactions include fever, chills, severe headache, nausea, vomiting, rapid heart rate, changes in blood pressure, body aches, and injection-site reactions.

Some symptoms could initially be mistaken for influenza, a stomach illness, dehydration, or an expected reaction to an injection. That can potentially complicate matters because a patient may not immediately connect a sudden illness with an injection received hours earlier.

Patients should therefore tell treating healthcare providers about any recent compounded glutathione injections when seeking medical attention for unexplained symptoms. The product name, dose, injection date, lot number, prescribing provider, and pharmacy can all be important information.

A serious reaction involving unstable blood pressure, rapid heart rate, severe vomiting, systemic inflammation, shock, or hospitalization may require considerably more treatment than an ordinary injection reaction. Medical records documenting when symptoms began and how they progressed can later become important evidence if a patient investigates a potential pharmaceutical injury lawsuit.

How Endotoxin Exposure Can Lead to Severe Illness

The immune system is designed to recognize substances associated with dangerous microorganisms. Endotoxins can activate a widespread inflammatory response as the body attempts to defend itself against what it perceives as a significant threat.

A severe response can potentially affect circulation and organ function. Blood pressure can fall, heart rate can change, and systemic inflammation can place considerable stress on the body.

This is why a patient who develops fever and chills following an injection should not automatically assume the reaction is harmless. The FDA’s previous investigation of excessive endotoxins associated with injectable glutathione identified hypotension, shock, and death among the potential consequences of inappropriate endotoxin exposure.

The severity of an individual reaction can depend on numerous factors, including the amount of endotoxin exposure, method of administration, patient’s underlying condition, and speed with which appropriate treatment is provided.

Why Compounded Injectable Medications Present Different Safety Issues

Compounded medications can serve important medical purposes, particularly when a patient requires a formulation that is not commercially available in an appropriate form. However, compounded medications are not the same as FDA-approved drugs.

FDA-approved medications ordinarily undergo a formal premarket review process addressing safety, effectiveness, manufacturing, labeling, and other regulatory requirements. Compounded medications generally do not undergo that same FDA premarket approval process.

That distinction can be especially significant with sterile injectable products.

Sterility and contamination controls become critical because the product is intended to enter the patient’s body through an injection. Problems involving raw ingredients, equipment, environmental conditions, preparation procedures, storage, handling, or quality-control testing can potentially affect patient safety.

The FDA has specifically warned compounders that quality must be built into sterile drug production rather than relying solely on end-product testing. It has also emphasized the importance of using ingredients manufactured under conditions and specifications appropriate for their intended injectable use.

Injectable Glutathione Has Become Popular in the Wellness Industry

Glutathione is naturally produced by the human body and functions as an antioxidant. Injectable forms have increasingly appeared in wellness clinics, medical spas, longevity practices, and other settings.

Injectable glutathione has been promoted for purposes that may include skin brightening, reducing hyperpigmentation, supporting immune function, combating oxidative stress, and so-called detoxification. However, these marketing claims should not be confused with FDA approval.

The FDA has not approved injectable glutathione for these widely promoted wellness and cosmetic purposes, and the benefits of such treatments have not been established through the FDA approval process.

The growth of wellness injections can make contamination events particularly concerning because consumers may perceive an injection offered through a medical or wellness environment as inherently safe.

A patient may reasonably focus on whether the treatment works without realizing that how an injectable medication was compounded can be just as important to immediate safety.

What Patients With Recalled Glutathione Should Do

Patients possessing a recalled vial should stop using the affected product immediately and quarantine it according to the recall instructions. The pharmacy is arranging retrieval and proper disposition of affected products. Anyone experiencing symptoms potentially associated with the recalled medication should contact a healthcare provider promptly.

Patients considering a potential legal claim should also avoid unnecessarily destroying evidence before documenting it. Photographs can establish the product name, concentration, lot number, expiration date, labeling, and condition of the packaging.

Relevant documentation can include:

• Photographs of the vial and packaging;
• Prescription and dispensing information;
• Lot and expiration numbers;
• Receipts or payment records;
• Dates and doses of injections;
• Communications from the pharmacy or prescribing provider;
• Recall letters, emails, or text messages;
• Emergency room and hospital records; and
• Documentation showing when symptoms first appeared.

These records can help establish whether a patient’s exposure involved a recalled lot and whether the timing of the illness is consistent with the injection.

Potential Compounded Glutathione Recall Lawsuits

Patients seriously injured after receiving recalled compounded glutathione may have potential legal claims depending upon the circumstances surrounding their treatment and injury.

A pharmaceutical injury lawsuit involving contaminated compounded medication can examine much more than whether a recall occurred. Attorneys may investigate where the ingredients originated, how the medication was compounded, what quality-control procedures were followed, how endotoxin testing was performed, whether testing revealed problems before distribution, and when potentially responsible parties first became aware of adverse events.

Potential legal theories could include negligence, product liability, failure to warn, manufacturing or compounding defects, and other claims permitted by the law governing an individual case.

Identifying responsible parties can also require tracing the medication through its distribution chain. Depending upon the circumstances, an investigation may consider the compounding pharmacy, ingredient suppliers, distributors, healthcare facilities, prescribing entities, or other businesses involved with the medication.

The availability and viability of claims against any particular party must be determined from the evidence and applicable state law.

Medical Damages After a Serious Contaminated Injection Reaction

A patient who develops a severe systemic reaction may require emergency treatment, hospitalization, diagnostic testing, medications, monitoring, and follow-up care.

Some patients may recover relatively quickly. Others could potentially suffer complications requiring substantial medical treatment.

A lawsuit involving a serious injury may seek compensation for damages such as past and future medical expenses, lost wages, diminished earning capacity, pain and suffering, disability, and other losses recognized under applicable law.

Cases involving fatal injuries may raise wrongful death and survival claims. The damages available in those cases vary considerably by state.

For a national law firm evaluating a contaminated medication claim, determining where the patient received the medication, where the medication was compounded and distributed, where the injury occurred, and which defendants participated in the distribution chain can all affect the legal analysis.

Why Medical Records Can Become Critical Evidence

Medical documentation can be particularly important in a pharmaceutical contamination case because causation is often disputed.

Records can establish the patient’s health before the injection, when the medication was administered, when symptoms appeared, what symptoms occurred, what physicians observed, laboratory findings, treatment provided, and the patient’s subsequent recovery.

Timing can be particularly significant.

For example, a patient who was stable before receiving an injection and then developed fever, chills, vomiting, tachycardia, or blood pressure abnormalities shortly afterward may have medical records that help attorneys and medical professionals evaluate whether the symptoms are consistent with the reported contamination hazard.

Patients should provide physicians with accurate information concerning what they received and when. That information can improve medical decision-making while simultaneously creating a clearer contemporaneous record of the event.

Filing a Compounded Glutathione Injury Lawsuit

A lawsuit begins with determining whether there is evidence connecting the patient’s injury with an affected product.

Attorneys may examine pharmacy records, prescription records, lot information, medical records, recall documentation, adverse-event reports, laboratory results, manufacturing and compounding information, and communications between companies and regulators.

The investigation may also seek answers to several important questions: What caused the elevated endotoxin levels? When did the problem begin? How many vials were affected? Were appropriate tests performed before the medication was dispensed? Were earlier adverse events reported? When did responsible parties learn about those events? Were physicians and patients warned promptly?

Those questions can determine whether a viable claim exists and which companies or individuals may bear legal responsibility.

Patients should also remember that statutes of limitations restrict the amount of time available to file lawsuits. Those deadlines differ between states and can depend upon the facts surrounding the injury. Waiting until every aspect of a recall investigation has been completed could therefore jeopardize legal rights.

Injured After Receiving Recalled Compounded Glutathione? Contact Parker Waichman LLP

Patients receiving an injectable medication have every reason to expect that the product was properly compounded, tested, handled, and prepared for injection. When potentially contaminated medication reaches patients, a treatment intended to improve someone’s health can instead result in an emergency room visit, hospitalization, severe systemic reaction, or potentially life-threatening complications.

If you or a family member received VMC Compounded Glutathione 200 mg/mL or another compounded glutathione injection and subsequently developed fever, chills, severe vomiting, rapid heart rate, blood pressure abnormalities, shock, or another serious reaction, consider having the circumstances investigated.

Parker Waichman LLP represents injured consumers nationwide in pharmaceutical, defective product, and serious personal injury litigation. The firm can investigate the medication involved, determine whether it came from an affected lot, obtain relevant medical and pharmacy records, identify potentially responsible parties, and evaluate whether a lawsuit may be appropriate.

Parker Waichman LLP offers free consultations to individuals and families affected by dangerous or potentially contaminated medications. Call 1-800-YOUR-LAWYER (1-800-968-7529) to discuss your potential case. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.